Chronic Myelomonocytic Leukemia-0

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Chronic Myelomonocytic Leukemia-0 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 1/2

NCT04734990

Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

This phase I/II trial identifies the best dose of seclidemstat when given together with azacitidine in treating patients with myelodysplastic syndrome or chroni…

United States24 participantsStarted 2021-07-07

Treatment: Azacitidine, Seclidemstat